Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Namiko Suda is active.

Publication


Featured researches published by Namiko Suda.


Japanese Journal of Cancer Research | 2001

Seaweed Prevents Breast Cancer

Hiroomi Funahashi; Tsuneo Imai; Takahiro Mase; Masanori Sekiya; Kazuki Yokoi; Hiromichi Hayashi; Arihiro Shibata; Takako Hayashi; Mikiko Nishikawa; Namiko Suda; Yatsuka Hibi; Yutaka Mizuno; Kyosuke Tsukamura; Akemi Hayakawa; Sei-ichi Tanuma

To investigate the chemopreventive effects of seaweed on breast cancer, we have been studying the relationship between iodine and breast cancer. We found earlier that the seaweed, wakame, showed a suppressive effect on the proliferation of DMBA (dimethylbenz(a)anthracene)‐induced rat mammary tumors, possibly via apoptosis induction. In the present study, powdered mekabu was placed in distilled water, and left to stand for 24 h at 4°C. The filtered supernatant was used as mekabu solution. It showed an extremely strong suppressive effect on rat mammary carcinogenesis when used in daily drinking water, without toxicity. In vitro, mekabu solution strongly induced apoptosis in 3 kinds of human breast cancer cells. These effects were stronger than those of a chemothera‐peutic agent widely used to treat human breast cancer. Furthermore, no apoptosis induction was observed in normal human mammary cells. In Japan, mekabu is widely consumed as a safe, inexpensive food. Our results suggest that mekabu has potential for chemoprevention of human breast


International Workshop on Digital Mammography | 2014

Clinical Evaluation of Dual Mode Tomosynthesis

Tokiko Endo; Mikinao Ooiwa; Takako Morita; Namiko Suda; Kazuaki Yoshikawa; Misaki Shiraiwa; Yukie Hayashi; Takao Horiba; Yasuyuki Sato; Syu Ichihara; Tomonari Sendai; Tetsuro Kusunoki; Takahisa Arai

Clinical performance achieved by adding interpretation of Tomosynthesis images to 2D images (hereinafter 2D+Tomo) was studied. 100 cases who gave written informed consent (ST mode: angular range ±7.5deg, 50 cases and HR mode: ±20deg, 50 cases) were obtained and 7 radiologists interpreted all images. In ST, the sensitivity is significantly increased by 15% (P<.01) and specificity is equivalent (P=.73). In HR, sensitivity of 2D+Tomo against 2D alone is significantly increased by 30% (P<.001) and specificity is significantly decreased by 5% (P<.01). ST, which has higher sensitivity and equivalent specificity, can be used for screening, and HR, which can visualize structures such as lesions in details, can be used for diagnosis. Moreover, specificity enhancement due to inhibition of false positive and sensitivity enhancement are confirmed by trial for appropriate segmentation in Japanese category classification C3. Further detailed clinical performance will be studied such as in ROC analysis with more cases.


Biochemical and Biophysical Research Communications | 2003

Function of the loop residue Thr792 in human DNA topoisomerase IIα

Namiko Suda; Yoshiyuki Nakagawa; Akihiko Kikuchi; Masako Sawada; Yuko Takami; Hiroomi Funahashi; Akimasa Nakao; Shonen Yoshida; Motoshi Suzuki

We studied the mutation effect of one of the putative loop residues Thr792 in human DNA topoisomerase II alpha (TOP2 alpha). Thr792 mutants were expressed from high or low copy plasmids in a temperature sensitive yeast strain deficient in TOP2 (top2-1). When expressed from a high copy plasmid, mutants with small side chains complemented the yeast defect; however, from a low copy plasmid, only wild-type, Ser, and Cys substitution mutants complemented the yeast defect. Interestingly, at the permissive temperature other mutants (e.g., Val, Gly, and Glu substitutions) showed the dominant negative effect to the top2-1 allele, which was not observed by the control alpha 4-helix mutants. T792E mutant was 10-fold less active than wild-type and the T792P had no decatenation activity in vitro. These results suggest that Thr792 in human TOP2 alpha is involved in enzyme catalysis.


Nucleic Acids Research | 2004

The α4 residues of human DNA topoisomerase IIα function in enzymatic activity and anticancer drug sensitivity

Namiko Suda; Yasutomo Ito; Tsuneo Imai; Toyone Kikumori; Akihiko Kikuchi; Yukihiro Nishiyama; Shonen Yoshida; Motoshi Suzuki


Breast Cancer | 2017

Detectability comparison of modes in dual-mode digital breast tomosynthesis.

Tokiko Endo; Takako Morita; Mikinao Oiwa; Namiko Suda; Yasuyuki Sato; Shu Ichihara; Misaki Shiraiwa; Kazuaki Yoshikawa; Takao Horiba; Hirotoshi Ogawa; Yukie Hayashi; Tomonari Sendai; Takahisa Arai


Nihon Nyugan Kenshin Gakkaishi (journal of Japan Association of Breast Cancer Screening) | 2018

The Combined Assessment of Mammography and Ultrasound for Focal Asymmetric Densities: Consideration of the Difference between Simultaneous Combined Method and Separate Combined Method

Mikinao Oiwa; Satoko Abe; Yuko Okanami; Naoto Kato; Junya Minohata; Yumi Miyagi; Tokiko Endo; Takako Morita; Namiko Suda; Kouji Ohnuki


Breast Cancer | 2018

Diagnostic performance of digital breast tomosynthesis and full-field digital mammography with new reconstruction and new processing for dose reduction

Tokiko Endo; Takako Morita; Mikinao Oiwa; Namiko Suda; Yasuyuki Sato; Shu Ichihara; Misaki Shiraiwa; Kazuaki Yoshikawa; Takao Horiba; Hirotoshi Ogawa; Yukie Hayashi; Tomonari Sendai; Takahisa Arai


Nihon Nyugan Kenshin Gakkaishi (journal of Japan Association of Breast Cancer Screening) | 2015

How to Deal with Focal Asymmetric Densities on Mammography Screening Combined with Ultrasonography in Terms of Increased Specificity: 特異度向上のために

Mikinao Oiwa; Endo Tokiko; Takako Morita; Namiko Suda; Yasuyuki Sato; Takako Hayashi; Aya Kato; Hisashi Usami; Yasunori Ota; Shu Ichihara; Suzuko Moritani; Masaki Hasegawa; Akari Iwakoshi


Nihon Nyugan Kenshin Gakkaishi (journal of Japan Association of Breast Cancer Screening) | 2015

Inputting Results of Mammography Screening on the Terminal Screen -The Current Status and Prospect for Quality Control

Namiko Suda; Takako Morita; Tae Niwa; Ruriko Suzuki; Naomi Kobayashi; Mikinao Oiwa; Tokiko Endo


Nihon Nyugan Kenshin Gakkaishi (journal of Japan Association of Breast Cancer Screening) | 2015

Changes in Molecular Subtypes of Screen-detected vs. Symptomatic Breast Cancer: Temporal Changes at a Breast Center Hospital

Takako Morita; Namiko Suda; Mikinao Oiwa; Suzuko Moritani; Yasuyuki Sato; Takako Hayashi; Aya Kato; Shu Ichihara; Tokiko Endo

Collaboration


Dive into the Namiko Suda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shu Ichihara

Matsumoto Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yasuyuki Sato

The Breast Cancer Research Foundation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge